Neoadjuvant Immunotherapy in Early Stage Non-small-cell Lung Cancer Presenting as Synchronous Ground-glass Nodules
Neoadjuvant Anti-PD-1 Therapy in Early Stage Non-small-cell Lung Cancer Presenting as Synchronous Ground-glass Nodules: a Pilot Study
Sponsor: XiangNing Fu
This PHASE2 trial investigates Multiple Pulmonary Nodules and is currently completed. XiangNing Fu leads this study, which shows 6 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Oct 2025 — Present [monthly]
Completed PHASE2
Status: Unknown → Completed
-
Feb 2025 — Oct 2025 [monthly]
Unknown PHASE2
Status: Not Yet Recruiting → Unknown
-
Sep 2024 — Feb 2025 [monthly]
Not Yet Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Not Yet Recruiting PHASE2
▶ Show 1 earlier version
-
Sep 2019 — Jan 2021 [monthly]
Not Yet Recruiting PHASE2
First recorded
Jul 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- XiangNing Fu
For direct contact, visit the study record on ClinicalTrials.gov .